GTC Biotherapeutics (fka GTCB)

[DewDiligence]

LFB addendum re the BoD composition:

A notable feature of the LFB collaboration is that, if approved by GTC shareholders, the LFB share purchase will bring a new director from LFB to GTC's BoD. I consider this a good thing because GTC’s BoD is a little stodgy and could use some fresh blood.

If there’s a knock to be made on GTC’s BoD, it’s that five of the nine existing directors are old-timers who have been associated with GTC for ten years or longer. If the new LFB director replaces one of the old-timers, then the old guard will no longer have a voting majority. I consider this a positive.